Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Switching to a fixed-ratio combination of insulin degludec/liraglutide (IDegLira) is associated with improved glycaemic control in a real-world population with type 2 diabetes mellitus in the United Arab Emirates: Results from the multicentre, prospective INTENSIFY study.

Diabetes research and clinical practice·2022
Same author

Lack of secondary hyperparathyroidism in sub-group of vitamin D deficient postmenopausal women: Is VDR gene polymorphism behind this mystery?

Diabetes & metabolic syndrome·2022
Same author

Central obesity & dyslipidemia in HIV patients on antiretroviral therapy.

The Indian journal of medical research·2019
Same author

All 25-hydroxyvitamin D-deficient Indian postmenopausal women do not have secondary hyperparathyroidism.

Archives of osteoporosis·2018
Same author

Prevalence of hypothyroidism in pregnancy: An epidemiological study from 11 cities in 9 states of India.

Indian journal of endocrinology and metabolism·2016
Same author

Recurrent hypoglycaemia: a delayed presentation of Sheehan syndrome.

BMJ case reports·2014

Related Experiment Video

Updated: May 28, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Thyroid disorders and bone mineral metabolism.

Dinesh Kumar Dhanwal1

  • 1Department of Medicine, Maulana Azad Medical College, New Delhi - 110 002, India.

Indian Journal of Endocrinology and Metabolism
|October 4, 2011
PubMed
Summary

Thyrotoxicosis significantly impacts bone metabolism, leading to secondary osteoporosis. This review focuses on the bone effects of hyperthyroidism, a condition often overlooked in hypothyroidism research.

Keywords:
Bone metabolismIndiabone mineral densityhyperthyroidismhypothyroidismthyroid disorders

Related Experiment Videos

Last Updated: May 28, 2026

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation
07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Systemic Manifestations of Thyroid Disease

Background:

  • Thyroid diseases exert widespread systemic effects, notably on bone metabolism.
  • Thyrotoxicosis, including subclinical forms, is a recognized cause of secondary osteoporosis.
  • Hypothyroidism's impact on bone mineral metabolism is less pronounced and studied.

Purpose of the Study:

  • To review the significant impact of thyrotoxicosis on bone metabolism.
  • To highlight thyrotoxicosis as a key factor in secondary osteoporosis.
  • To differentiate the bone effects of hyperthyroidism versus hypothyroidism.

Main Methods:

  • Literature review focusing on thyrotoxicosis and bone metabolism.
  • Analysis of existing research on thyroid disease and bone density.
  • Synthesis of findings on hyperthyroid-induced bone changes.

Main Results:

  • Thyrotoxicosis accelerates bone turnover, increasing fracture risk.
  • Subclinical thyrotoxicosis also contributes to bone loss and osteoporosis.
  • The bone effects of hypothyroidism are minimal compared to hyperthyroidism.

Conclusions:

  • Thyrotoxicosis is a critical determinant of bone health, often leading to osteoporosis.
  • Understanding thyrotoxicosis's bone effects is crucial for clinical management.
  • Further research may be warranted to fully elucidate hypothyroidism's subtle bone effects.